Stryker received FDA 510(k) clearance to market its Pangea Systems including Femur, Fibula, Tibia, Humerus and Utility.
Pangea plates were designed to enhance plate fit and screw placement while elevating the plating market through anatomically contoured implants in patient populations with a wide variety of fracture patterns. Streamlined instrumentation and implant trays will include 20 anatomic plates and 13 utility plates all accessible in one platform.
“FDA clearance is a critical milestone for our Pangea Systems,” said Eric Tamweber, Vice President and General Manager, Stryker’s Trauma business unit. “With these new systems, we are now offering surgeons a comprehensive portfolio that supports a wide range of their trauma needs.”
Stryker received FDA 510(k) clearance to market its Pangea Systems including Femur, Fibula, Tibia, Humerus and Utility.
Pangea plates were designed to enhance plate fit and screw placement while elevating the plating market through anatomically contoured implants in patient populations with a wide variety of fracture patterns. Streamlined...
Stryker received FDA 510(k) clearance to market its Pangea Systems including Femur, Fibula, Tibia, Humerus and Utility.
Pangea plates were designed to enhance plate fit and screw placement while elevating the plating market through anatomically contoured implants in patient populations with a wide variety of fracture patterns. Streamlined instrumentation and implant trays will include 20 anatomic plates and 13 utility plates all accessible in one platform.
“FDA clearance is a critical milestone for our Pangea Systems,” said Eric Tamweber, Vice President and General Manager, Stryker’s Trauma business unit. “With these new systems, we are now offering surgeons a comprehensive portfolio that supports a wide range of their trauma needs.”
Copy to clipboard 
